42
Views
3
CrossRef citations to date
0
Altmetric
Review

Intraoperative adjuncts for parathyroid surgery

&
Pages 245-253 | Published online: 10 Jan 2014

References

  • Melton GB, Somervell H, Friedman KP, Zeiger MA, Cahid Civelek A. Interpretation of 99mTc sestamibi parathyroid SPECT scan is improved when read by the surgeon and nuclear medicine physician together. Nucl. Med. Commun.26(7), 633–638 (2005).
  • Eslamy HK, Ziessman HA. Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc sestamibi SPECT and SPECT/CT. Radiographics28(5), 1461–1476 (2008).
  • Caixàs A, Bernà L, Hernández A et al. Efficacy of preoperative diagnostic imaging localization of technetium 99m-sestamibi scintigraphy in hyperparathyroidism. Surgery121(5), 535–541 (1997).
  • Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol. Head Neck Surg.132(3), 359–372 (2005).
  • Solorzano CC, Carneiro-Pla DM, Irvin GL 3rd. Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J. Am. Coll. Surg.202(1), 18–24 (2006).
  • Berri RN, Lloyd LR. Detection of parathyroid adenoma in patients with primary hyperparathyroidism: the use of office-based ultrasound in preoperative localization. Am. J. Surg.191(3), 311–314 (2006).
  • Kairys JC, Daskalakis C, Weigel RJ. Surgeon-performed ultrasound for preoperative localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. World J. Surg.30(9), 1658–1663 (2006).
  • Mihai R, Barczynski M, Iacobone M, Sitges-Serra A. Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations. Langenbecks Arch. Surg.394(5), 785–798 (2009).
  • Chen H, Sokoll LJ, Udelsman R. Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery126(6), 1016–1021 (1999).
  • Sugg SL, Krzywda EA, Demeure MJ, Wilson SD. Detection of multiple gland primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Surgery136(6), 1303–1309 (2004).
  • Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL 3rd. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery134(6), 973–979 (2003).
  • Irvin GL 3rd, Solorzano CC, Carneiro DM. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J. Surg.28(12), 1287–1292 (2004).
  • Irvin GL 3rd. American Association of Endocrine Surgeons. Presidential address: chasin’ hormones. Surgery126(6), 993–997 (1999).
  • Irvin GL 3rd, Prudhomme DL, Deriso GT, Sfakianakis G, Chandarlapaty SK. A new approach to parathyroidectomy. Ann. Surg.219(5), 574–579 (1994).
  • Irvin GL 3rd, Sfakianakis G, Yeung L et al. Ambulatory parathyroidectomy for primary hyperparathyroidism. Arch. Surg.131(10), 1074–1078 (1996).
  • Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery138(4), 583–587 (2005).
  • Bieglmayer C, Kaczirek K, Prager G, Niederle B. Parathyroid hormone monitoring during total parathyroidectomy for renal hyperparathyroidism: pilot study of the impact of renal function and assay specificity. Clin. Chem.52(6), 1112–1119 (2006).
  • Sokoll LJ, Wians FH Jr, Remaley AT. Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for point-of-care testing. Clin. Chem.50(7), 1126–1135 (2004).
  • Maier GW, Kreis ME, Renn W, Pereira PL, Häring HU, Becker HD. Parathyroid hormone after adenectomy for primary hyperparathyroidism. A study of peptide hormone elimination kinetics in humans. J. Clin. Endocrinol. Metab.83(11), 3852–3856 (1998).
  • Hruska KA, Korkor A, Martin K, Slatopolsky E. Peripheral metabolism of intact parathyroid hormone. Role of liver and kidney and the effect of chronic renal failure. J. Clin. Invest.67(3), 885–892 (1981).
  • Riss P, Kaczirek K, Heinz G, Bieglmayer C, Niederle B. A “defined baseline” in PTH monitoring increases surgical success in patients with multiple gland disease. Surgery142(3), 398–404 (2007).
  • de Vos tot Nederveen Cappel R, Bouvy N, de Herder W, de Rijke Y, van Toor H, Bonjer J. Novel criteria for parathyroid hormone levels in parathyroid hormone-guided parathyroid surgery. Arch. Pathol. Lab. Med.131(12), 1800–1804 (2007).
  • Miller BS, England BG, Nehs M, Burney RE, Doherty GM, Gauger PG. Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of <100 pg/ml. Surgery140(6), 883–889 (2006).
  • Lombardi CP, Raffaelli M, Traini E. Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease. Langenbecks Arch. Surg.393(5), 639–645 (2008).
  • Cook MR, Pitt SC, Schaefer S, Sippel R, Chen H. A rising IOPTH level immediately after parathyroid resection: are additional hyperfunctioning glands always present? An application of the Wisconsin Criteria. Ann. Surg.251(6), 1127–1130 (2010).
  • Chiu B, Sturgeon C, Angelos P. Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients. Arch. Surg.141(5), 483–487 (2006).
  • Clerici T, Brandle M, Lange J, Doherty GM, Gauger PG. Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. World J. Surg.28(2), 187–192 (2004).
  • Carneiro-Pla DM, Solorzano CC, Lew JI, Irvin GL 3rd. Long-term outcome of patients with intraoperative parathyroid level remaining above the normal range during parathyroidectomy. Surgery144(6), 989–993 (2008).
  • Gannagé-Yared MH, Abboud B, Amm-Azar M et al. Predictors of intra-operative parathyroid hormone decline in subjects operated for primary hyperparathyroidism by minimally invasive parathyroidectomy. J. Endocrinol. Invest.32(2), 160–164 (2009).
  • Ito F, Sippel R, Lederman J, Chen H. The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann. Surg.245(6), 959–963 (2007).
  • Taylor J, Fraser W, Banaszkiewicz P, Drury P, Atkins P. Lateralization of parathyroid adenomas by intra-operative parathormone estimation. JR Coll. Surg. Edinb.41(3), 174–177 (1996).
  • Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W. Utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing in guiding patients with a negative sestamibi scan for minimally invasive parathyroidectomy – a randomized controlled trial. Langenbecks Arch. Surg.394(5), 827–835 (2009).
  • Sharma J, Milas M, Berber E, Mazzaglia P, Siperstein A, Weber CJ. Value of intraoperative parathyroid hormone monitoring. Ann. Surg. Oncol.15(2), 493–498 (2008).
  • Miccoli P, Berti P, Materazzi G, Ambrosini CE, Fregoli L, Donatini G. Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: a prospective randomized trial. Surg. Endosc.22(2), 398–400 (2008).
  • Udelsman R, Donovan PI. Open minimally invasive parathyroid surgery. World J. Surg.28(12), 1224–1226 (2004).
  • Bergson EJ, Sznyter LA, Dubner S, Palestro CJ, Heller KS. Sestamibi scans and intraoperative parathyroid hormone measurement in the treatment of primary hyperparathyroidism. Arch. Otolaryngol. Head Neck Surg.130(1), 87–91 (2004).
  • Carneiro-Pla DM, Solorzano CC, Irvin GL 3rd. Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J. Am. Coll. Surg.202(5), 715–722 (2006).
  • Nilsen FS, Haug E, Heidemann M, Karlsen SJ. Does rapid intraoperative parathyroid hormone analysis predict cure in patients undergoing surgery for primary hyperparathyroidism? A prospective study. Scand. J. Surg.95(1), 28–32 (2006).
  • Gil-Cárdenas A, Gamino R, Reza A, Pantoja JP, Herrera MF. Is intraoperative parathyroid hormone assay mandatory for the success of targeted parathyroidectomy? J. Am. Coll. Surg.204(2), 286–290 (2007).
  • Stalberg P, Sidhu S, Sywak M, Robinson B, Wilkinson M, Delbridge L. Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it ‘value-add’ to decision-making? J. Am. Coll. Surg.203(1), 1–6 (2006).
  • Gawande AA, Monchik JM, Abbruzzese TA, Iannuccilli JD, Ibrahim SI, Moore FD Jr. Reassessment of parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism after 2 preoperative localization studies. Arch. Surg.141(4), 381–384 (2006).
  • Mihai R, Palazzo FF, Gleeson FV, Sadler GP. Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism. Br. J. Surg.94(1), 42–47 (2007).
  • Pang T, Stalberg P, Sidhu S et al. Minimally invasive parathyroidectomy using the lateral focused mini-incision technique without intraoperative parathyroid hormone monitoring. Br. J. Surg.94(3), 315–319 (2007).
  • Conrad DN, Olson JE, Hartwig HM, Mack E, Chen H. A prospective evaluation of novel methods to intraoperatively distinguish parathyroid tissue utilizing a parathyroid hormone assay. J. Surg. Res.133(1), 38–41 (2006).
  • Elliott DD, Monroe DP, Perrier ND. Parathyroid histopathology: is it of any value today? J. Am. Coll. Surg.203(5), 758–765 (2006).
  • Perrier ND, Ituarte P, Kikuchi S et al. Intraoperative parathyroid aspiration and parathyroid hormone assay as an alternative to frozen section for tissue identification. World J. Surg.24(11), 1319–1322 (2000).
  • Chan RK, Ibrahim SI, Pil P, Tanasijevic M, Moore FD. Validation of a method to replace frozen section during parathyroid exploration by using the rapid parathyroid hormone assay on parathyroid aspirates. Arch. Surg.140(4), 371–373 (2005).
  • Lo CY, Chan WF, Leung P, Luk JM. Applicability of tissue aspirate for quick parathyroid hormone assay to confirm parathyroid tissue identity during parathyroidectomy for primary hyperparathyroidism. Arch. Surg.140(2), 146–149 (2005).
  • Pelizzo MR, Losi A, Boschin IM et al. Rapid intraoperative parathyroid hormone assay in fine needle aspiration for differential diagnosis in thyroid and parathyroid surgery. Clin. Chem. Lab. Med.48(9), 1313–1317 (2010).
  • Harrison BJ, Triponez F. Intraoperative adjuncts in surgery for primary hyperparathyroidism. Langenbecks Arch. Surg.394(5), 799–809 (2009).
  • Chen H, Mack E, Starling JR. Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann. Surg.238(3), 332–337 (2003).
  • Chen H, Mack E, Starling JR. A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable? Ann. Surg.242(3), 375–380 (2005).
  • Aaltonen T, Adelman J, Alvarez González B et al. Search for technicolor particles produced in association with a W Boson at CDF. Phys. Rev. Lett.104(11), 111802 (2010).
  • Rubello D, Casara D, Giannini S et al. Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low (99m)Tc-MIBI dose. Technical considerations and long-term clinical results. QJ Nucl. Med.47(2), 129–138 (2003).
  • Mariani G, Gulec SA, Rubello D et al. Preoperative localization and radioguided parathyroid surgery. J. Nucl. Med.44(9), 1443–1458 (2003).
  • Inabnet WB 3rd, Chun KK, Haber RS, Lopchinsky RA. Radioguidance is not necessary during parathyroidectomy. Arch.Surg.137(8), 967–970 (2002).
  • Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL. Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch. Surg.137(6), 659–668 (2002).
  • Burkey SH, Van Heerden JA, Farley DR, Thompson GB, Grant CS, Curlee KJ. Will directed parathyroidectomy utilizing the gamma probe or intraoperative parathyroid hormone assay replace bilateral cervical exploration as the preferred operation for primary hyperparathyroidism? World J. Surg.26(8), 914–920 (2002).
  • McGreal G, Winter DC, Sookhai S. Minimally invasive, radioguided surgery for primary hyperparathyroidism. Ann. Surg. Oncol.8(10), 856–860 (2001).
  • Chen H, Sippel RS, Schaefer S. The effectiveness of radioguided parathyroidectomy in patients with negative technetium tc 99m-sestamibi scans. Arch. Surg.144(7), 643–648 (2009).
  • Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery126(6), 1023–1028 (1999).
  • Friedman M, Gurpinar B, Schalch P, Joseph NJ. Guidelines for radioguided parathyroid surgery. Arch. Otolaryngol. Head Neck Surg.133(12), 1235–1239 (2007).
  • Ugur O, Bozkurt MF, Hamaloglu E. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Arch. Surg.139(11), 1175–1179 (2004).
  • Pitt SC, Sippel RS, Chen H. Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg. Clin. North Am.89(5), 1227–1239 (2009).
  • Weigel TL, Murphy J, Kabbani L, Ibele A, Chen H. Radioguided thoracoscopic mediastinal parathyroidectomy with intraoperative parathyroid hormone testing. Ann. Thorac. Surg.80(4), 1262–1265 (2005).
  • Wild JL, Weigel T, Chen H. The need for intraoperative parathyroid hormone monitoring during radioguided parathyroidectomy by video-assisted thoracoscopy (VATS). Clin. Nucl. Med.31(1), 9–12 (2006).
  • Lal A, Bianco J, Chen H. Radioguided parathyroidectomy in patients with familial hyperparathyroidism. Ann. Surg. Oncol.14(2), 739–743 (2007).
  • Pitt SC, Panneerselvan R, Sippel RS, Chen H. Radioguided parathyroidectomy for hyperparathyroidism in the reoperative neck. Surgery146(4), 592–598 (2009).
  • Cayo A, Chen H. Radioguided reoperative parathyroidectomy for persistent primary hyperparathyroidism. Clin. Nucl. Med.33(10), 668–670 (2008).
  • Anton RC, Wheeler TM. Frozen section of thyroid and parathyroid specimens. Arch. Pathol. Lab. Med.129(12), 1575–1584 (2005).
  • Hosking SW, Jones H, du Boulay CE, McGinn FP. Surgery for parathyroid adenoma and hyperplasia: relationship of histology to outcome. Head Neck15(1), 24–28 (1993).
  • Saxe AW, Baier R, Tesluk H, Toreson W. The role of the pathologist in the surgical treatment of hyperparathyroidism. Surg. Gynecol. Obstet.161(2), 101–105 (1985).
  • Westra WH, Pritchett DD, Udelsman R. Intraoperative confirmation of parathyroid tissue during parathyroid exploration: a retrospective evaluation of the frozen section. Am. J. Surg. Pathol.22(5), 538–544 (1998).
  • Dewan AK, Kapadia SB, Hollenbeak CS, Stack BC Jr. Is routine frozen section necessary for parathyroid surgery? Otolaryngol. Head Neck Surg.133(6), 857–862 (2005).
  • Osamura RY, Hunt JL. Current practices in performing frozen sections for thyroid and parathyroid pathology. Virchows Arch.453(5), 433–440 (2008).
  • Meilstrup JW. Ultrasound examination of the parathyroid glands. Otolaryngol. Clin. North Am.37(4), 763–778, ix (2004).
  • Hajioff D, Iyngkaran T, Panagamuwa C, Hill D, Stearns MP. Preoperative localization of parathyroid adenomas: ultrasonography, sestamibi scintigraphy, or both? Clin. Otolaryngol. Allied Sci.29(5), 549–552 (2004).
  • Mekel M, Mahajna A, Ish-Shalom S et al. Minimally invasive surgery for treatment of hyperparathyroidism. Isr. Med. Assoc. J.7(5), 323–327 (2005).
  • Terris DJ, Stack BC Jr, Gourin CG. Contemporary parathyroidectomy: exploiting technology. Am. J. Otolaryngol.28(6), 408–414 (2007).
  • Purcell GP, Dirbas FM, Jeffrey RB et al. Parathyroid localization with high-resolution ultrasound and technetium Tc 99m sestamibi. Arch. Surg.134(8), 824–828 (1999).
  • Joshua B, Feinmesser R, Ulanovski D et al. Primary hyperparathyroidism in young adults. Otolaryngol. Head Neck Surg.131(5), 628–632 (2004).
  • Casara D, Rubello D, Pelizzo MR, Shapiro B. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur. J. Nucl. Med.28(9), 1351–1359 (2001).
  • Kebebew E, Arici C, Duh QY, Clark OH. Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch. Surg.136(8), 878–885 (2001).
  • Liew V, Gough IR, Nolan G, Fryar B. Re-operation for hyperparathyroidism. ANZ J. Surg.74(9), 732–740 (2004).
  • Ghaheri BA, Koslin DB, Wood AH, Cohen JI. Preoperative ultrasound is worthwhile for reoperative parathyroid surgery. Laryngoscope114(12), 2168–2171 (2004).
  • Dudley NE. Methylene blue for rapid identification of the parathyroids. Br. Med. J.3(5776), 680–681 (1971).
  • Pollack G, Pollack A, Delfiner J, Fernandez J. Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use. Laryngoscope119(10), 1941–1946 (2009).
  • Kuriloff DB, Sanborn KV. Rapid intraoperative localization of parathyroid glands utilizing methylene blue infusion. Otolaryngol. Head Neck Surg.131(5), 616–622 (2004).
  • Derom AF, Wallaert PC, Janzing HM, Derom FE. Intraoperative identification of parathyroid glands with methylene blue infusion. Am. J. Surg.165(3), 380–382 (1993).
  • Traynor S, Adams JR, Andersen P, Everts E, Cohen J. Appropriate timing and velocity of infusion for the selective staining of parathyroid glands by intravenous methylene blue. Am. J. Surg.176(1), 15–17 (1998).
  • Han N, Bumpous JM, Goldstein RE, Fleming MM, Flynn MB. Intra-operative parathyroid identification using methylene blue in parathyroid surgery. Am. Surg.73(8), 820–823 (2007).
  • Martin RC 2nd, Greenwell D, Flynn MB. Initial neck exploration for untreated hyperparathyroidism. Am. Surg.66(3), 269–272 (2000).
  • Ahmed TS. Methylene blue toxicity following infusion to localize parathyroid adenoma. J. Laryngol. Otol.120(8), 708; author reply 708–709 (2006).
  • Sweet G, Standiford SB. Methylene-blue-associated encephalopathy. J. Am. Coll. Surg.204(3), 454–458 (2007).
  • Kartha SS, Chacko CE, Bumpous JM, Fleming M, Lentsch EJ, Flynn MB. Toxic metabolic encephalopathy after parathyroidectomy with methylene blue localization. Otolaryngol. Head Neck Surg.135(5), 765–768 (2006).
  • Vutskits L, Briner A, Klauser P. Adverse effects of methylene blue on the central nervous system. Anesthesiology108(4), 684–692 (2008).
  • Flisberg K, Lindholm T. Electrical stimulation of the human recurrent laryngeal nerve during thyroid operation. Acta Otolaryngol. Suppl.263, 63–67 (1969).
  • Shedd DP, Durham C. Electrical identification of the recurrent laryngeal nerve. I. Response of the canine larynx to electrical stimulation of the recurrent laryngeal nerve. Ann. Surg.163(1), 47–50 (1966).
  • Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann. Surg.235(5), 665–670 (2002).
  • Allendorf J, DiGorgi M, Spanknebel K, Inabnet W, Chabot J, Logerfo P. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J. Surg.31(11), 2075–2080 (2007).
  • Dralle H, Sekulla C, Haerting J. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery136(6), 1310–1322 (2004).
  • Friedrich T, Staemmler A, Hänsch U, Würl P, Steinert M, Eichfeld U. [Intraoperative electrophysiological monitoring of the recurrent laryngeal nerve in thyroid gland surgery – a prospective study]. Zentralbl. Chir.127(5), 414–420 (2002).
  • Witt RL. Recurrent laryngeal nerve electrophysiologic monitoring in thyroid surgery: the standard of care? J. Voice19(3), 497–500 (2005).
  • Chan WF, Lang BH, Lo CY. The role of intraoperative neuromonitoring of recurrent laryngeal nerve during thyroidectomy: a comparative study on 1000 nerves at risk. Surgery140(6), 866–872 (2006).
  • Shindo M, Chheda NN. Incidence of vocal cord paralysis with and without recurrent laryngeal nerve monitoring during thyroidectomy. Arch. Otolaryngol. Head Neck Surg.133(5), 481–485 (2007).
  • Snyder SK, Hendricks JC. Intraoperative neurophysiology testing of the recurrent laryngeal nerve: plaudits and pitfalls. Surgery138(6), 1183–1191 (2005).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.